LogicBio Therapeutics, Inc

(NASDAQ:LOGC)

Latest On LogicBio Therapeutics, Inc (LOGC):

Date/Time Type Description Signal Details
2022-11-16 14:25 ESTNewsAstraZeneca's Alexion completes acquisition of genomic medicine company LogicBioN/A
2022-11-14 11:21 ESTNewsLogicBio GAAP EPS of -$0.18 beats by $0.02, revenue of $2.72M beats by $0.72MN/A
2022-10-03 13:25 ESTNewsLogicBio jumps 648% on buyout deal with AstraZeneca unit AlexionN/A
2022-08-15 18:03 ESTNewsLogicBio GAAP EPS of -$0.15, revenue of $3.2MN/A
2022-05-24 22:23 ESTNewsLogicBio Therapeutics (LOGC) Investor Presentation - SlideshowN/A
2022-05-16 14:46 ESTNewsLogicBio GAAP EPS of -$0.20, revenue of $2.81MN/A
2022-05-09 12:48 ESTNewsLogicBio surges as FDA lifts clinical hold on lead assetN/A
2022-03-05 01:32 ESTNewsLogicBio GAAP EPS of -$1.24 beats by $0.08, revenue of $5.41M beats by $0.56MN/A
2022-02-04 06:43 ESTNewsLogicBio downgraded at William Blair citing lack of clarity on catalysts after clinical holdN/A
2022-02-02 21:14 ESTNewsLogicBio falls on FDA clinical hold on gene therapy program for metabolic diseaseN/A
2021-11-22 05:25 ESTNewsWarning: LOGC is at high risk of performing badlyN/A
2021-08-09 10:42 ESTNewsLogicBio EPS misses by $0.14, misses on revenueN/A
2021-07-21 14:47 ESTNewsLogicBio trades higher as gene editing stocks rallyN/A
2021-04-27 20:08 ESTNewsLogicBio announces agreements with CANbridge Pharma and Daiichi SankyoN/A
2021-03-17 13:05 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 03:33 ESTNewsLogicBio EPS misses by $0.03, beats on revenueN/A
2021-03-16 21:18 ESTEarnings EstimateAn EPS average of -$1.44 is estimated for the 2022 year.Sell
2021-03-16 21:18 ESTEarnings EstimateAn EPS average of -$0.28 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-05 15:54 ESTAnalyst RatingThe Analyst Target Price has decreased from $21.33 to $20.25.Neutral
2021-01-07 13:46 ESTNewsLogicBio extends collaboration with Children's Medical Research InstituteN/A
2021-01-06 16:04 ESTFinancialsCompany financials have been released.Neutral
2020-12-22 22:33 ESTNewsLogicBio Therapeutics names new CFON/A
2020-11-26 20:42 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 13:08 ESTNewsLooking In On LogicBioN/A
2020-11-12 12:15 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 12:21 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 04:21 ESTAnalyst RatingThe Analyst Target Price has decreased from $22 to $21.33.Neutral
2020-11-10 04:21 ESTEarnings EstimateAn EPS average of -$0.41 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-09 13:15 ESTNewsLogicBio reports Q3 resultsN/A
2020-11-07 16:22 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 08:43 ESTNewsLogicBio's LB-001 Fast Track'd for methylmalonic acidemia; shares +10%N/A
2020-11-05 08:43 ESTNewsLogicBio's LB-001 fast track'd in U.S. for an inherited metabolic disorderN/A
2020-11-04 05:37 ESTNewsLogicBio Therapeutics announces executive leadership changesN/A
2020-10-05 17:57 ESTInsider TradeErez Chimovits has indirectly acquired of 296,296 shares.Buy
2020-10-05 17:57 ESTInsider TradeErez Chimovits has indirectly acquired of 639,212 shares.Buy
2020-10-05 17:57 ESTInsider TradeErez Chimovits has indirectly acquired of 545,974 shares.Buy
2020-10-05 17:57 ESTInsider TradeORBIMED ADVISORS LLC has indirectly acquired of 296,296 shares.Buy
2020-10-05 17:57 ESTInsider TradeORBIMED ADVISORS LLC has indirectly acquired of 639,212 shares.Buy
2020-10-05 17:57 ESTInsider TradeORBIMED ADVISORS LLC has indirectly acquired of 545,974 shares.Buy
2020-10-05 17:15 ESTInsider TradeBioscience plc Arix has indirectly disposed of 273,584 shares.Sell
2020-10-05 17:15 ESTInsider TradeBioscience plc Arix has indirectly disposed of 174,219 shares.Sell
2020-10-05 17:15 ESTInsider TradeBioscience plc Arix has indirectly disposed of 38,514 shares.Sell
2020-10-01 17:12 ESTNewsLogicBio readies equity offeringN/A
2020-10-01 17:10 ESTNewsLogicBio Therapeutics -30% on pricing of equity offeringN/A
2020-09-26 13:17 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:24 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:21 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 05:12 ESTFinancialsCompany financials have been released.Neutral
2020-08-11 21:15 ESTAnalyst RatingThe Analyst Target Price has increased from $20.33 to $22.Buy
2020-08-11 05:05 ESTFinancialsCompany financials have been released.Neutral

About LogicBio Therapeutics, Inc (LOGC):

LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect. The company's lead product candidate is LB-001 for the treatment of Methylmalonic Acidemia, a life-threatening disease that presents at birth. It has a partnership with Children's Medical Research Institute to develop new viral vectors; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop new genome editing candidate LB-301 for the treatment of crigler-najjar syndrome. The company was founded in 2014 and is headquartered in Lexington, Massachusetts.

See Advanced Chart

General

  • Name LogicBio Therapeutics, Inc
  • Symbol LOGC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Fiscal Year EndDecember
  • IPO Date2018-10-19
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.logicbio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 61.91
  • Price/Book (Most Recent Quarter) 4.4
  • Enterprise Value Revenue 62.53
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.16
  • Next Year EPS Estimate -$1.12
  • Next Quarter EPS Estimate -$0.35
  • Operating Margin -912%
  • Return on Assets -29%
  • Return on Equity -63%
  • Revenue 3.45 million
  • Earnings Per Share -$1.55
  • Revenue Per Share $0.14
  • Gross Profit 3.45 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 254.61 million
  • EBITDA -30350000
  • PE Ratio -0.64
  • Analyst Target Price $20.25
  • Book Value Per Share $1.93
View More

Share Statistics

  • Shares Outstanding 31.79 million
  • Shares Float 17.29 million
  • % Held by Insiders 1369%
  • % Held by Institutions 53%
  • Shares Short 827300
  • Shares Short Prior Month 677650
  • Short Ratio 6.35
  • Short % of Float 4%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 1.31
  • 52 Week High $10
  • 52 Week Low $4.02
  • 50 Day Moving Average 8.36
  • 200 Day Moving Average 7.32
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

LogicBio Therapeutics, Inc (LOGC) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

LogicBio Therapeutics, Inc (LOGC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-16$N/A-$0.22-$0.3231.25%
2020-09-302020-11-09$N/A-$0.34-$0.4117.58%
2020-06-302020-08-10$N/A-$0.35-$0.4827.08%
2020-03-312020-05-11$1.02 million-$0.41-$0.4814.23%
2019-12-312020-03-16$N/A-$0.51-$0.49-5.15%
2019-09-302019-11-12$N/A-$0.48-$0.47-3.23%
2019-06-302019-08-13$N/A-$0.45-$0.40-12.5%
2019-03-312019-05-14$N/A-$0.34-$0.29-18.26%
2018-12-312018-12-31$N/A-$0.41-$0.39-5.13%
2018-09-302018-12-03$N/A-$4.03-$3.87-4.27%

LogicBio Therapeutics, Inc (LOGC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A 7.17 million 8.38 million
Income Before Tax N/A N/A N/A -9.46 million -11.47 million
Selling General Administrative N/A N/A N/A 3.19 million 3.05 million
Gross Profit N/A N/A N/A N/A N/A
Ebit N/A N/A N/A -9.18 million -11.43 million
Operating Income N/A N/A N/A -9.34 million -11.43 million
Income Tax Expense 188000 N/A N/A N/A N/A
Total Revenue N/A N/A N/A 1.02 million N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A -6000 -33000
Net Income From Continuing Operations N/A N/A N/A -9.46 million -11.47 million
Net Income Applicable to Common Shares -6.9 million -8.04 million -8.23 million N/A -11.47 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A 7 million N/A
Change to Liabilities 423000 -2.63 million N/A -1.31 million N/A
Total Cash Flow from Investing Activities -141000 -202000 N/A 6.67 million N/A
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A N/A 81000 N/A
Change to Operating Activities 654000 893000 N/A 202000 N/A
Change in Cash N/A N/A N/A -4.95 million N/A
Total Cash from Operating Activities -5.59 million -8.31 million N/A -11.7 million N/A
Depreciation N/A N/A N/A 100000 N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 1.25 million 1.54 million N/A 767000 N/A
Capital Expenditures N/A N/A N/A 331000 N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A N/A 15.04 million 13.37 million
Total Stockholder Equity N/A N/A N/A 33.71 million 42.29 million
Other Current Liabilities 443000 N/A N/A N/A 276000
Total Assets N/A N/A N/A 48.75 million 55.66 million
Common Stock 3000 22.29 million 28.16 million N/A 3000
Other Current Assets N/A N/A N/A N/A 146000
Retained Earnings -99.99 million N/A N/A N/A -67.37 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets 622000 9.52 million 10.65 million N/A 622000
Cash N/A N/A N/A N/A 33.11 million
Total Current Liabilities 6.15 million 19.52 million N/A 15.04 million 3.56 million
Other Stockholder Equity N/A N/A N/A N/A 14000
Property, Plant & Equipment 7.48 million N/A N/A N/A 2.2 million
Total Current Assets 72.54 million 32.29 million N/A 43.15 million 52.84 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 61.43 million 22.29 million 28.16 million N/A 42.29 million
Short Term Investments N/A N/A N/A N/A 17.54 million
Long Term Debt N/A N/A N/A N/A 9.81 million
Inventory N/A N/A N/A N/A N/A
Accounts Payable 447000 19.52 million N/A N/A 624000

LogicBio Therapeutics, Inc (LOGC) Chart:

LogicBio Therapeutics, Inc (LOGC) News:

Below you will find a list of latest news for LogicBio Therapeutics, Inc (LOGC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

LogicBio Therapeutics, Inc (LOGC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-1610CALL0 00TRUE00
2025-05-1620CALL0 0828.68TRUE00
2025-05-1630CALL0 0392.15TRUE00
2025-05-1640CALL0 0326.72TRUE00
2025-05-1650CALL0 0241.89TRUE00
2025-05-1661.12CALL0 62152.08TRUE00
2025-05-1670.65CALL5 36685.57TRUE0.150.3
2025-05-1680.25CALL51 6879.84FALSE0.050.25
2025-05-1690.05CALL4 3968.6FALSE-0.04-0.44
2025-05-16100CALL0 0181.63FALSE00
2025-05-16110CALL0 0188.6FALSE00
2025-05-16120CALL0 0209.37FALSE00
2025-05-16130CALL0 0246.62FALSE00
2025-05-16140CALL0 0268.03FALSE00
2025-05-16150CALL0 0242.5FALSE00
2025-05-1610PUT0 0414.05FALSE00
2025-05-1620PUT0 0269.2FALSE00
2025-05-1630PUT0 0234.2FALSE00
2025-05-1640PUT0 0165.45FALSE00
2025-05-1650.2PUT0 4186.36FALSE00
2025-05-1660.15PUT0 9377.54FALSE00
2025-05-1670.69PUT0 8106.37FALSE00
2025-05-1680PUT0 0109.88TRUE00
2025-05-1690PUT0 087.14TRUE00
2025-05-16100PUT0 0159.37TRUE00
2025-05-16113.53PUT0 1168.61TRUE00
2025-05-16120PUT0 0261.72TRUE00
2025-05-16130PUT0 0281.54TRUE00
2025-05-16140PUT0 0331.72TRUE00
2025-05-16150PUT0 0363.81TRUE00
2025-06-2010CALL0 0284.9TRUE00
2025-06-2020CALL0 0214.25TRUE00
2025-06-2030CALL0 0356.02TRUE00
2025-06-2040CALL0 0205.44TRUE00
2025-06-2050CALL0 060.31TRUE00
2025-06-2060CALL0 066.79TRUE00
2025-06-2070CALL0 083.85TRUE00
2025-06-2080.53CALL0 397.57FALSE00
2025-06-2090.25CALL5 1770.17FALSE0.250
2025-06-20100CALL0 069.85FALSE00
2025-06-20110CALL0 0116.54FALSE00
2025-06-20120CALL0 0129.47FALSE00
2025-06-20130CALL0 0140.85FALSE00
2025-06-2010PUT0 0596.93FALSE00
2025-06-2020PUT0 0330.34FALSE00
2025-06-2030PUT0 0234.55FALSE00
2025-06-2040PUT0 0161.53FALSE00
2025-06-2050PUT0 0125.47FALSE00
2025-06-2060PUT0 0102.57FALSE00
2025-06-2070PUT0 080.99FALSE00
2025-06-2080PUT0 079.23TRUE00
2025-06-2090PUT0 093.67TRUE00
2025-06-20100PUT0 093.24TRUE00
2025-06-20110PUT0 0108.21TRUE00
2025-06-20120PUT0 0189.99TRUE00
2025-06-20130PUT0 0212.39TRUE00
2025-07-1810CALL0 0230.16TRUE00
2025-07-1820CALL0 0172.73TRUE00
2025-07-1830CALL0 0273.23TRUE00
2025-07-1840CALL0 0217.17TRUE00
2025-07-1851.83CALL0 182791.36TRUE00
2025-07-1861.51CALL0 39888.44TRUE00
2025-07-1871.2CALL10 150382.96TRUE1.20
2025-07-1880.7CALL0 283775.61FALSE00
2025-07-1890.5CALL0 12999.39FALSE00
2025-07-18101.39CALL0 173.39FALSE00
2025-07-18110.32CALL0 282.56FALSE00
2025-07-18120CALL0 0105.63FALSE00
2025-07-18130CALL0 0114.96FALSE00
2025-07-18140CALL0 0123.3FALSE00
2025-07-18150.25CALL0 9110.09FALSE00
2025-07-18160CALL0 0137.69FALSE00
2025-07-18170CALL0 0143.99FALSE00
2025-07-18180CALL0 0149.81FALSE00
2025-07-1810PUT0 0503.88FALSE00
2025-07-1820PUT0 0337.56FALSE00
2025-07-1830PUT0 0192.62FALSE00
2025-07-1840PUT0 0140.43FALSE00
2025-07-1850PUT0 0100.35FALSE00
2025-07-1860.9PUT0 13486.86FALSE00
2025-07-1870.91PUT200 5273.5FALSE0.910
2025-07-1881.9PUT0 199.13TRUE00
2025-07-1890PUT0 095.67TRUE00
2025-07-18100PUT0 0115.91TRUE00
2025-07-18110PUT0 095.59TRUE00
2025-07-18120PUT0 0149.7TRUE00
2025-07-18130PUT0 0168.26TRUE00
2025-07-18140PUT0 0200.9TRUE00
2025-07-18150PUT0 0182.71TRUE00
2025-07-18160PUT0 0198.65TRUE00
2025-07-18170PUT0 0206.05TRUE00
2025-07-18180PUT0 0174.43TRUE00
2025-10-1710CALL0 0151.97TRUE00
2025-10-1720CALL0 0290.49TRUE00
2025-10-1730CALL0 0163.13TRUE00
2025-10-1740CALL0 081.2TRUE00
2025-10-1750CALL0 062.25TRUE00
2025-10-1761.7CALL0 7565.4TRUE00
2025-10-1771.4CALL0 2278.55TRUE00
2025-10-1781.1CALL0 3589.41FALSE00
2025-10-1790CALL0 096.03FALSE00
2025-10-17100.64CALL0 277073.7FALSE00
2025-10-17110CALL0 075.81FALSE00
2025-10-17120CALL0 072.51FALSE00
2025-10-17130.3CALL0 173.62FALSE00
2025-10-17140.48CALL0 288.34FALSE00
2025-10-17150CALL0 090.11FALSE00
2025-10-17160CALL0 094.9FALSE00
2025-10-17170CALL0 097.37FALSE00
2025-10-17180.2CALL0 2044103.35FALSE00
2025-10-1710PUT0 0406.42FALSE00
2025-10-1720PUT0 0189.79FALSE00
2025-10-1730PUT0 0135.11FALSE00
2025-10-1740PUT0 098.8FALSE00
2025-10-1750.55PUT0 20075.06FALSE00
2025-10-1761.1PUT0 5178.8FALSE00
2025-10-1771.46PUT0 41073.52FALSE00
2025-10-1781.9PUT0 2583.97TRUE00
2025-10-1790PUT0 070.6TRUE00
2025-10-17103.09PUT0 275.64TRUE00
2025-10-17113.8PUT0 982.63TRUE00
2025-10-17120PUT0 085.12TRUE00
2025-10-17130PUT0 078.56TRUE00
2025-10-17140PUT0 0144.22TRUE00
2025-10-17150PUT0 0137.46TRUE00
2025-10-17160PUT0 0146.06TRUE00
2025-10-17170PUT0 0148.8TRUE00
2025-10-171811.6PUT0 1133.84TRUE00
2026-01-1610CALL0 3115.94TRUE00
2026-01-1620CALL0 2141.53TRUE00
2026-01-1634.15CALL0 15283.74TRUE00
2026-01-1643.4CALL0 21977.35TRUE00
2026-01-1652.75CALL0 171033.78TRUE00
2026-01-1660CALL0 079.25TRUE00
2026-01-1671.9CALL17 1082074.68TRUE00
2026-01-1681.45CALL0 5074.69FALSE00
2026-01-1690CALL0 099.9FALSE00
2026-01-16101.06CALL0 169155.69FALSE00
2026-01-16120.63CALL0 10973.08FALSE00
2026-01-16150.3CALL0 356262.81FALSE00
2026-01-16170.5CALL0 288.62FALSE00
2026-01-1610PUT0 41248.85FALSE00
2026-01-1620PUT0 72155.11FALSE00
2026-01-1630.15PUT0 45110.62FALSE00
2026-01-1640.45PUT0 91489.47FALSE00
2026-01-1650.85PUT0 202074.69FALSE00
2026-01-1661.12PUT0 5068.9FALSE00
2026-01-1672PUT0 2874.26FALSE00
2026-01-1680PUT0 078.25TRUE00
2026-01-1690PUT0 083.32TRUE00
2026-01-16100PUT0 078.83TRUE00
2026-01-16120PUT0 076.83TRUE00
2026-01-16150PUT0 089.12TRUE00
2026-01-16170PUT0 0108.49TRUE00

Latest LOGC Trades:

Date Shares Price
Jun 13, 2022 7:47 PM EST200$0.4539
Jun 13, 2022 7:50 PM EST100$0.4499
Jun 13, 2022 7:50 PM EST200$0.4499
Jun 13, 2022 7:50 PM EST100$0.4499
Jun 13, 2022 7:50 PM EST100$0.4477

LogicBio Therapeutics, Inc (LOGC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520178928/0001193125-20-178928-index.htm
2019-11-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1664106/000000000019015732/0000000000-19-015732-index.htm
2020-05-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1664106/000000000020004765/0000000000-20-004765-index.htm
2020-06-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1664106/000000000020005085/0000000000-20-005085-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026987/0000899243-18-026987-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026988/0000899243-18-026988-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026992/0000899243-18-026992-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026993/0000899243-18-026993-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026994/0000899243-18-026994-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026998/0000899243-18-026998-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318026999/0000899243-18-026999-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027001/0000899243-18-027001-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027002/0000899243-18-027002-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027005/0000899243-18-027005-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027007/0000899243-18-027007-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027010/0000899243-18-027010-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027011/0000899243-18-027011-index.htm
2018-10-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027012/0000899243-18-027012-index.htm
2018-10-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027096/0000899243-18-027096-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027210/0000899243-18-027210-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027211/0000899243-18-027211-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027212/0000899243-18-027212-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027213/0000899243-18-027213-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027217/0000899243-18-027217-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027218/0000899243-18-027218-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027219/0000899243-18-027219-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027222/0000899243-18-027222-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027225/0000899243-18-027225-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027226/0000899243-18-027226-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027227/0000899243-18-027227-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027229/0000899243-18-027229-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027231/0000899243-18-027231-index.htm
2018-10-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027375/0000899243-18-027375-index.htm
2018-10-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027378/0000899243-18-027378-index.htm
2018-10-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027379/0000899243-18-027379-index.htm
2018-10-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027380/0000899243-18-027380-index.htm
2018-10-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027381/0000899243-18-027381-index.htm
2018-10-253/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027415/0000899243-18-027415-index.htm
2018-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027475/0000899243-18-027475-index.htm
2018-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027477/0000899243-18-027477-index.htm
2018-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027478/0000899243-18-027478-index.htm
2018-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027480/0000899243-18-027480-index.htm
2018-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027481/0000899243-18-027481-index.htm
2018-10-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924318027509/0000899243-18-027509-index.htm
2019-02-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924319004572/0000899243-19-004572-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924319004574/0000899243-19-004574-index.htm
2019-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924319022576/0000899243-19-022576-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000089924320027297/0000899243-20-027297-index.htm
2019-05-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1664106/000090266419002407/0000902664-19-002407-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1664106/000090266420000940/0000902664-20-000940-index.htm
2018-11-01SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1664106/000094787118000868/0000947871-18-000868-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000094787120000776/0000947871-20-000776-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000094787120000777/0000947871-20-000777-index.htm
2020-10-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1664106/000094787120000780/0000947871-20-000780-index.htm
2018-10-09S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1664106/000119312518295666/0001193125-18-295666-index.htm
2018-10-11S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1664106/000119312518297645/0001193125-18-297645-index.htm
2018-10-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1664106/000119312518300264/0001193125-18-300264-index.htm
2018-10-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1664106/000119312518300269/0001193125-18-300269-index.htm
2018-10-17S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1664106/000119312518301103/0001193125-18-301103-index.htm
2018-10-178-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1664106/000119312518301114/0001193125-18-301114-index.htm
2018-10-19POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1664106/000119312518302176/0001193125-18-302176-index.htm
2018-10-22424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1664106/000119312518303289/0001193125-18-303289-index.htm
2018-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312518310599/0001193125-18-310599-index.htm
2018-11-02SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1664106/000119312518317070/0001193125-18-317070-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312518340421/0001193125-18-340421-index.htm
2018-12-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000119312518341169/0001193125-18-341169-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312518354565/0001193125-18-354565-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1664106/000119312519036007/0001193125-19-036007-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1664106/000119312519036039/0001193125-19-036039-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519057916/0001193125-19-057916-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519093656/0001193125-19-093656-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1664106/000119312519094593/0001193125-19-094593-index.htm
2019-04-02S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1664106/000119312519095708/0001193125-19-095708-index.htm
2019-04-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519105205/0001193125-19-105205-index.htm
2019-04-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519110925/0001193125-19-110925-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1664106/000119312519125202/0001193125-19-125202-index.htm
2019-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1664106/000119312519125235/0001193125-19-125235-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519146010/0001193125-19-146010-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000119312519146603/0001193125-19-146603-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519180202/0001193125-19-180202-index.htm
2019-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519184362/0001193125-19-184362-index.htm
2019-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519188256/0001193125-19-188256-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519219514/0001193125-19-219514-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000119312519219972/0001193125-19-219972-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519288366/0001193125-19-288366-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312519289315/0001193125-19-289315-index.htm
2019-11-15S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1664106/000119312519293465/0001193125-19-293465-index.htm
2019-11-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1664106/000119312519297651/0001193125-19-297651-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520005091/0001193125-20-005091-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520029995/0001193125-20-029995-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520074884/0001193125-20-074884-index.htm
2020-03-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1664106/000119312520075995/0001193125-20-075995-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520080815/0001193125-20-080815-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1664106/000119312520124363/0001193125-20-124363-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1664106/000119312520124383/0001193125-20-124383-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520139024/0001193125-20-139024-index.htm
2020-06-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1664106/000119312520161349/0001193125-20-161349-index.htm
2020-06-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1664106/000119312520162213/0001193125-20-162213-index.htm
2020-06-0510-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1664106/000119312520162226/0001193125-20-162226-index.htm
2020-06-0510-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000119312520162248/0001193125-20-162248-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520171447/0001193125-20-171447-index.htm
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520178928/0001193125-20-178928-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520214074/0001193125-20-214074-index.htm
2020-09-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1664106/000119312520257792/0001193125-20-257792-index.htm
2020-09-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1664106/000119312520259681/0001193125-20-259681-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520259688/0001193125-20-259688-index.htm
2020-10-02424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1664106/000119312520262477/0001193125-20-262477-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520263197/0001193125-20-263197-index.htm
2020-11-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1664106/000119312520284838/0001193125-20-284838-index.htm
2019-11-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119057546/0001209191-19-057546-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119060530/0001209191-19-060530-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061660/0001209191-19-061660-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061662/0001209191-19-061662-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061663/0001209191-19-061663-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061664/0001209191-19-061664-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061665/0001209191-19-061665-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061666/0001209191-19-061666-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919119061671/0001209191-19-061671-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120009447/0001209191-20-009447-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120009448/0001209191-20-009448-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120009449/0001209191-20-009449-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120009450/0001209191-20-009450-index.htm
2020-03-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120020340/0001209191-20-020340-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120020355/0001209191-20-020355-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120024991/0001209191-20-024991-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120024992/0001209191-20-024992-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120024993/0001209191-20-024993-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038659/0001209191-20-038659-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038661/0001209191-20-038661-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038662/0001209191-20-038662-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038664/0001209191-20-038664-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038665/0001209191-20-038665-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038667/0001209191-20-038667-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1664106/000120919120038668/0001209191-20-038668-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1664106/000121390020003725/0001213900-20-003725-index.htm
2020-02-21SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1664106/000121390020004495/0001213900-20-004495-index.htm
2018-10-18CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1664106/000135445718000419/0001354457-18-000419-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000156459019042912/0001564590-19-042912-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1664106/000156459020011170/0001564590-20-011170-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000156459020024240/0001564590-20-024240-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1664106/000156459020038622/0001564590-20-038622-index.htm
2018-10-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1664106/999999999518002661/9999999995-18-002661-index.htm
2019-11-25EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1664106/999999999519002659/9999999995-19-002659-index.htm
2018-10-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1664106/999999999718008680/9999999997-18-008680-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1664106/999999999719003401/9999999997-19-003401-index.htm

LogicBio Therapeutics, Inc (LOGC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of LogicBio Therapeutics, Inc (LOGC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1369%
Institutional Ownership: 5300%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-10-23Tomer KarivDirectorBuy207,151.0010.002,071,510.001,574,564.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027480/0000899243-18-027480-index.htm
2018-10-23Tomer KarivDirectorBuy112,000.0010.001,120,000.001,686,564.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027480/0000899243-18-027480-index.htm
2018-10-23Sofia IoannidouDirectorBuy420,000.0010.004,200,000.001,787,413.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027478/0000899243-18-027478-index.htm
2018-10-23Tomer KarivDirectorBuy100,849.0010.001,008,490.001,787,413.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027480/0000899243-18-027480-index.htm
2020-09-28Bioscience plc Arix10% Share HolderSell273,584.007.542,061,865.822,381,436.00https://www.sec.gov/Archives/edgar/data/1664106/000089924320027297/0000899243-20-027297-index.htm
2020-09-25Bioscience plc Arix10% Share HolderSell174,219.007.081,232,947.862,655,020.00https://www.sec.gov/Archives/edgar/data/1664106/000089924320027297/0000899243-20-027297-index.htm
2020-09-24Bioscience plc Arix10% Share HolderSell38,514.007.63293,823.312,829,239.00https://www.sec.gov/Archives/edgar/data/1664106/000089924320027297/0000899243-20-027297-index.htm
2020-10-01Erez ChimovitsDirectorBuy296,296.006.001,777,776.00296,296.00https://www.sec.gov/Archives/edgar/data/1664106/000094787120000776/0000947871-20-000776-index.htm
2020-10-01ORBIMED ADVISORS LLCDirectorBuy296,296.006.001,777,776.00296,296.00https://www.sec.gov/Archives/edgar/data/1664106/000094787120000777/0000947871-20-000777-index.htm
2018-10-23Bioscience plc Arix10% Share HolderBuy700,000.0010.007,000,000.002,979,023.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027509/0000899243-18-027509-index.htm
2018-10-23Daniel P O'ConnellDirectorBuy700,000.0010.007,000,000.002,979,023.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027477/0000899243-18-027477-index.htm
2018-10-23Erez ChimovitsDirectorBuy490,000.0010.004,900,000.003,487,760.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027475/0000899243-18-027475-index.htm
2020-10-01Erez ChimovitsDirectorBuy545,974.006.003,275,844.003,524,997.00https://www.sec.gov/Archives/edgar/data/1664106/000094787120000776/0000947871-20-000776-index.htm
2020-10-01ORBIMED ADVISORS LLCDirectorBuy545,974.006.003,275,844.003,524,997.00https://www.sec.gov/Archives/edgar/data/1664106/000094787120000777/0000947871-20-000777-index.htm
2020-10-01Erez ChimovitsDirectorBuy639,212.006.003,835,272.004,126,972.00https://www.sec.gov/Archives/edgar/data/1664106/000094787120000776/0000947871-20-000776-index.htm
2020-10-01ORBIMED ADVISORS LLCDirectorBuy639,212.006.003,835,272.004,126,972.00https://www.sec.gov/Archives/edgar/data/1664106/000094787120000777/0000947871-20-000777-index.htm
2018-10-23ORBIMED ADVISORS LLCDirectorBuy490,000.0010.004,900,000.005,766,783.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027481/0000899243-18-027481-index.htm
2018-10-23ORBIMED ADVISORS LLCDirectorBuy700,000.0010.007,000,000.006,466,783.00https://www.sec.gov/Archives/edgar/data/1664106/000089924318027481/0000899243-18-027481-index.htm
2019-08-27Thomas WiltonChief Business OfficerBuy75,000.000.7354,750.0075,000.00https://www.sec.gov/Archives/edgar/data/1664106/000089924319022576/0000899243-19-022576-index.htm